ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,962Medicare Part D Prescriptions Filled, Including Refills

Rank: 514 out of 1844

$412K Total Retail Price of All Prescriptions

Rank: 513 out of 1844

456 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 6,213 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 294 255 1 3
FUROSEMIDE 191 182 2 7
BISOPROLOL-HYDROCHLOROTHIAZIDE 171 160 3 99
PANTOPRAZOLE SODIUM 157 137 4 32
METFORMIN HCL 156 140 5 8
CITALOPRAM HBR 146 122 6 19
TRAMADOL HCL-ACETAMINOPHEN 145 128 7 159
LISINOPRIL 145 139 7 4
MELOXICAM 144 135 9 28
LEVOTHYROXINE SODIUM 143 126 10 1
PREDNISONE 131 124 11 40
OMEPRAZOLE 129 112 12 5
CEPHALEXIN 127 119 13 56
AMLODIPINE BESYLATE 122 117 14 6
GLYBURIDE-METFORMIN HCL 121 117 R 15 140
HYDROCODONE-ACETAMINOPHEN 107 56 S3 16 2
ATENOLOL 93 93 17 17
TAMSULOSIN HCL 92 80 18 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 72 19 20
POTASSIUM CHLORIDE 82 76 20 16
INDAPAMIDE 79 73 21 210
ATORVASTATIN CALCIUM 79 79 21 12
TRAMADOL HCL 78 62 23 18
ZOLPIDEM TARTRATE 77 64 24 23
GABAPENTIN 76 57 25 15
DOXYCYCLINE HYCLATE 74 70 26 90
LOSARTAN POTASSIUM 72 60 27 24
ALLOPURINOL 65 65 28 29
WARFARIN SODIUM 64 64 29 13
PRAVASTATIN SODIUM 63 46 30 10
AMLODIPINE BESYLATE-BENAZEPRIL 61 58 31 80
SPIRONOLACTONE-HCTZ 57 57 32 203
CARVEDILOL 56 56 33 22
HYDROCHLOROTHIAZIDE 54 47 34 9
METOPROLOL SUCCINATE 54 50 34 14
SERTRALINE HCL 54 46 34 21
PEN NEEDLE 52 47 37 135
LEVEMIR FLEXPEN 51 49 38 166
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 5, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.